Clinical trial of low dose dexmedetomidine in the treatment of patients with intracranial aneurysm during anesthesia induction
10.13699/j.cnki.1001-6821.2024.20.008
- VernacularTitle:麻醉诱导期应用小剂量右美托咪定在颅内动脉瘤患者中的临床研究
- Author:
Jun-Long HUANG
1
;
Dong-Bin GUO
;
Bing LI
;
Jian-Jun ZHOU
Author Information
1. 福建医科大学附属龙岩市第一医院神经外科,福建龙岩 364000
- Keywords:
dexmedetomidine hydrochloride injection;
anesthesia induction period;
intracranial aneurysms;
intracranial pressure waveform
- From:
The Chinese Journal of Clinical Pharmacology
2024;40(20):2949-2953
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical efficacy and safety of low dose dexmedetomidine for postoperative stability in patients with intracranial aneurysm during anesthesia induction.Method Patients with intracranial aneurysms treated with intracranial aneurysm clipping+intracranial pressure probe implantation were divided into treatment group and control group by cohort method.The patients in the control group were given intravenous midazolam injection 0.1 mg·kg-1 and cisatracurium 0.15 mg·kg-1 before the start of anesthesia induction to complete the anesthesia induction,and the endotracheal tube was inserted to observe the patient's breathing.Patients in the treatment group were given intravenous infusion of dexmedetomidine hydrochloride injection 0.4 μg·kg-1·h-1 from 15 min before anesthesia induction to the end of surgery;and the other drugs were the same as those in the control group.The hemodynamic indexes,sedation quality and recovery score,intracranial pressure waveform parameters were compared between the two groups before anesthesia induction(T1),immediately after anesthesia induction(T2),at tracheal intubation(T3),at aneurysm clipping(T4),at the end of operation(T5)and 2 min after extubation(T6),and the safety was evaluated.Results The control group and the treatment group were enrolled in 40 patients.The heart rate(HR)at T6 in the treatment group and the control group were(82.31±9.73)and(86.91±10.36)beat·min-1,respectively;the sedation-agitation scale(SAS)were 3.22±0.75 and 3.58±0.80,respectively;the mean waveform amplitude(MWA)on the first day after operation were(3.42±0.75)and(3.76±0.69)mmHg,respectively;the MWA on the second day after operation were(2.68±0.63)and(2.98±0.57)mmHg,respectively;the relationship of amplitude and pressure(RAP)on the first day after operation were 0.46±0.11 and 0.52±0.12,respectively.The above indexes in the treatment group were significantly different from those in the control group(all P＜0.05).There was no significant difference in Ramsay sedation score(Ramsay),anesthesia recovery time and visual analogue scale(VAS)score at 6 h after operation between the treatment group and the control group(all P＞0.05).The total incidence of adverse drug reactions during the wake-up period in the treatment group and the control group was 25.00％(10 cases/40 cases)and 36.84％(14 cases/38 cases),respectively,with no statistically significant difference(P＞0.05).Conclusion The application of low-dose dexmedetomidine hydrochloride injection in the induction period of anesthesia can stabilize the intracranial pressure waveform parameters,blood pressure,heart rate,respiratory rate,etc.after intracranial aneurysm surgery.
